Xinqiao Hospital Of Chongqing

This early-phase study tests a new mRNA therapy for people with severe autoimmune diseases like lupus or immune anemia. The treatment uses lipid nanoparticles to deliver mRNA that targets and clears harmful B cells. The goal is to control the disease and reduce symptoms, but ongo…

This early-phase trial tests an mRNA immunotherapy for people with tumors linked to the Epstein-Barr virus, such as nasopharyngeal cancer, gastric cancer, and lymphoma. The treatment aims to train the immune system to recognize and attack virus-infected cancer cells. Researchers …

This study tests whether giving the blood thinner eptifibatide right after standard clot-busting therapy helps people who had a stroke 4.5 to 24 hours earlier. About 786 adults with moderate to severe stroke will be randomly assigned to receive eptifibatide or not. The goal is to…